Mettler-Toledo International, Inc. MTD
1,511.64
(7.51)
(0.49%)
as of 25 Sep
- Market cap
- $30.4B
- P/E
- 33.9×
Follow MTD
Indexes
indicate stock being part of an index
Mettler-Toledo International, Inc. (MTD) P/E ratio
As of 25 September 2026, Mettler-Toledo International, Inc. (MTD) trades at a P/E ratio of 33.9×. Over the past ten years it has ranged from 22.6× (October 2015) to 53.0× (September 2021); the current reading is higher than 50% of that period. That is in line with the Diagnostics & Research industry median of 33.9× and above the Healthcare sector median of 22.7×.
P/E ratio, daily
Annual
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 33.0× | 9.81% |
| FY2024 | 30.1× | (10.63%) |
| FY2023 | 33.6× | (10.62%) |
| FY2022 | 37.6× | (26.19%) |
| FY2021 | 51.0× | 13.09% |
| FY2020 | 45.1× | 30.03% |
| FY2019 | 34.7× | 24.81% |
| FY2018 | 27.8× | (35.13%) |
| FY2017 | 42.8× | 47.43% |
| FY2016 | 29.0× | 9.55% |
Quarterly
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 28.7× | (2.78%) |
| Mar 2026 | 29.5× | (10.62%) |
| Dec 2025 | 33.0× | 8.14% |
| Sep 2025 | 30.5× | 2.97% |
| 42 more quarters | Free account |
Against its own ten years
Low 22.6×
High 53.0×
Ten-year median
34.0×
Current reading's percentile
50
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| GH Guardant Health, Inc. compare | n/m |
| DGX Quest Diagnostics Incorporated compare | 24.8× |
| LH Labcorp Holdings Inc. compare | 25.4× |
| IQV IQVIA Holdings Inc. compare | 33.3× |
| MTD Mettler-Toledo International, Inc. | 33.9× |
| A Agilent Technologies, Inc. compare | 33.9× |
| IDXX IDEXX Laboratories, Inc. compare | 36.2× |
| ILMN Illumina, Inc. compare | 50.4× |
| WAT Waters Corporation compare | 108× |
| Diagnostics & Research industry median | 33.9× |
| Healthcare sector median | 22.7× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on MTD
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement